<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>EARLY CLINICAL MANIFESTATIONS OF TROPHOBLASTIC DISEASE IN WOMEN WITH UNDEVELOPED PREGNANCY</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given"></mods:namePart><mods:namePart type="family">Yusupova D.O.</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Matyakubova</mods:namePart><mods:namePart type="family">S.A.</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Trophoblastic disease is characteristic only of pregnant women of reproductive age and occurs in 0.1-0.25% of all pregnancies. Cystic fibrosis is most often diagnosed among this pathology. According to WHO (2011), on average, there is one cystic fibrosis per 1,000 births, and approximately 2 out of 100,000 women develop chorioncinoma after childbirth and in the same proportion after abortions.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-02-23</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>